HOME >> MEDICINE >> NEWS
Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

(PHILADELPHIA) -- The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, the researchers say.

The team of scientists including first author Jose Moreno, M.D., clinical associate professor of urology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and the Kimmel Cancer Center at Jefferson looked at circulating tumor cells (CTCs) in 240 men with metastatic prostate cancer that failed hormone-depletion therapy. They compared levels prior to chemotherapy and after two to five weeks of treatment. They found that those men with more than five tumor cells per blood sample had a worse prognosis than those who had fewer cells. One half of the patients with more than five CTCs lived at least 10 months, whereas half of the men with fewer tumor cells lived substantially longer 21 months.

Dr. Moreno presents the trials findings June 4, 2007 at the annual meeting of the American Society of Clinical Oncology in Chicago.

The results of the 65-site trial also showed that those patients who underwent chemotherapy and whose CTC number went down fared better and had a more favorable prognosis. That is, the level of response to chemotherapy was reflected in the CTC level, notes Dr. Moreno. The numbers held up even after up to 20 weeks of treatment. If chemotherapy doesnt reduce the CTC level, its information that enables the physician to change the drug regimen or perhaps stop treatment, he says.

Dr. Moreno notes that the prostate specific antigen has been a powerful biomarker for cancer presence and a useful way to gauge treatment effectiveness for years, though it has some flaws. He thinks that th
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
4-Jun-2007


Page: 1 2

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Trials underway for essential new TB vaccine
3. ENDEAVOR III Trial reports key findings on new-generation stent
4. NIH names Clinical Trial Units for the Microbicide Trials Network
5. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
6. The Public Library of Science launches the new open access journal PLoS Clinical Trials
7. Trial shows vaccine against cervical cancer provides long-term protection
8. Trial shows malaria vaccine could protect young children from disease for 18 months
9. Trial demonstrates new drugs effectiveness against psoriasis
10. Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
11. Second implant of US Pilot Trial achieved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/9/2020)... , ... April 09, 2020 , ... ... developers in the 2020 Outpatient Healthcare Real Estate Development Report. The report, produced ... magazine, ranked firms based on total square footage of outpatient construction projects started ...
(Date:4/9/2020)... (PRWEB) , ... April 09, 2020 , ... T1 ... to assist in providing support to shelter residents, and anyone who may be experiencing ... crisis hotline remains fully operational as many families and individuals struggle with increased financial, ...
(Date:4/7/2020)... (PRWEB) , ... April 07, 2020 , ... ... overcrowding due to the pandemic, FieldMed, a dedicated community health software platform, announced ... practitioners to connect patients directly with doctors without ever leaving their homes. In ...
(Date:4/5/2020)... ... April 05, 2020 , ... In ... help our healthcare industry. Nufabrx®, a proprietary biomaterial company that seamlessly embeds active ... and Manufacturing Solutions Center, has shifted production for a new line of reusable ...
(Date:4/2/2020)... NEW YORK (PRWEB) , ... April 02, 2020 , ... ... for restaurants regarding food safety standards and practices. GoParrot ( https://www.goparrot.ai/ ) founder ... with doctors who specialize in virus control and food safety, has created new standards ...
Breaking Medicine News(10 mins):
(Date:4/7/2020)... ... April 07, 2020 , ... A multinational consensus statement from the Fleischner Society ... jointly published today in the journals Radiology and Chest. , “We ... this statement was to offer guidance that is sensitive to these differences and applicable ...
(Date:4/5/2020)... ... April 04, 2020 , ... In ... facility into a factory producing non-medical cloth facemasks. , On March 18th when ... use of non-medical cloth face masks if no medical-grade facemasks were available, SwaddleDesigns ...
(Date:4/2/2020)... (PRWEB) , ... April 02, 2020 , ... Planning an ... , Despite best efforts to the contrary, having nonconformities spotted by a notified ... , Companies will be under a strict deadline and under pressure with only 15 ...
Breaking Medicine Technology:
Cached News: